Article Text

Download PDFPDF
Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Handling editor Josef S Smolen

  • Twitter @stezhao, @dpsg108

  • Contributors Both authors contributed to all stages of this research.

  • Funding SSZ is supported by a National Institute for Health Research Clinical Lectureship and works in centres supported by Versus Arthritis (grant numbers 21755, 21173, 21754 and 21755). DG is supported by the British Heart Foundation Research Centre of Excellence (RE/18/4/34215) at Imperial College London. This research was funded by UK Research and Innovation Medical Research Council (MC_UU_00002/7).

  • Competing interests DG is employed part-time by Novo Nordisk. All authors declare no conflicts of interest that could bias this work.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability UK Biobank data are available to all bona fide researchers for use in health-related research that is in the public interest. The application procedure is described at www.ukbiobank.ac.uk.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.